IRVINE, Calif., Aug. 4, 2006 (PRIMEZONE) -- "Savvy investors are focusing on industries where the enormous population of aging Baby Boomers are now spending their money," stated SmallCap Sentinel analyst, D.R. Clark. "During the Baby Boomer years, approximately 76 million Americans were born. Today, this represents 28 percent of the American population. The aging of this demographic will naturally cause a greater consumption of imperative goods and services led most obviously by health care."
"Companies are aggressively growing their health care related business plans with product development and licensing agreements, broadening their revenue-seeking footprint as the boomers head toward their golden years," Clark added.
"One such company is Auriga Laboratories(tm), Inc. (OTCBB:ARGA), which develops and sells prescription products for drugs that utilize innovative delivery technologies and reformulation strategies," Clark stated. "With more Boomers hitting their primary health care consuming years each day, innovation in this industry is intriguing for a multitude of reasons."
The informational report "The Silver Tsunami: Baby Boomers & Biotech Breakthroughs" has been made available free of charge via financial courier StockUpTicks.com at www.SmallCapSentinel.com
The report will detail various issues affecting the current market for biotechnology companies including Baxter International Inc. (NYSE:BAX), Intuitive Surgical Inc (Nasdaq:ISRG), ev3, Inc. (Nasdaq:EVVV) and Auriga Laboratories.
Auriga Laboratories, Inc., a specialty pharmaceutical company, engages in the development and marketing of prescription products for drugs using drug delivery technologies and reformulation strategies. It offers Extendryl(R), a prescription cough/cold medication. The company's products address disease treatment in various areas, such as cough and cold medications, gastrointestinal disorders, and central nervous system disorders. Auriga Laboratories is based in Norcross, Georgia
Individuals may also register for future reports at: http://stockupticks.com/register.html
Statements made herein contain forward-looking statements and are subject to significant risks and uncertainties that affect results. SmallCap Sentinel and StockUpTicks.com are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect any proposed actions and cannot project capabilities, intent, resources, or experience.
All information contained herein is based upon sources believed to be reliable but no representation is made as to its accuracy or completeness. This report is neither a solicitation to buy, nor offer to sell securities but is rather a paid advertisement provided for information purposes only and should not be used as the basis for any investment decision. MP is not an investment advisor and this report is not investment advice. MP has been paid $1,500 by Auriga Laboratories for preparation and distribution of this report and other advertising services. This constitutes a conflict of interest as to MP's ability to remain objective in its communication regarding the subject companies.